Start free

Fulgent Genetics, Inc. (FLGT) insider trading

Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Oct 28, 2026.

Filings shown
25
Open-market buys
0
Open-market sells
8

Counts cover the 25 most recent Form 4 filings Tradune holds for FLGT (filed May 18 – Oct 28, 2026); the score below covers only the trailing 90 days (0 buys, 4 sells). SEC EDGAR Form 4 filings for FLGT last checked Nov 21, 2026, 09:00 UTC; the latest FLGT filing Tradune holds was filed Oct 28, 2026. This is not guaranteed to be the complete record — see FLGT's full Form 4 filing history on SEC EDGAR.

Open-market activity, last 90 days

Purchases (Form 4 code P) and sales (code S) on the 11 filings Tradune holds for FLGT filed Aug 28 – Oct 28, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.

4 open-market sales by Rule 10b5-1 checkbox

On filings with the 10b5-1 box checked
0 sales· 0 sh
checkbox disclosed
On filings with the box not checked
4 sales· 5,932 sh
not proof that no plan exists
Not comparable
0 sales· 0 sh
filed before Apr 1, 2023, or no checkbox value in the filing data

Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.

Open-market purchases and sales by insider
Insider Buys Sells Shares bought Shares sold Value
Jian XiePresident and COO 0 2 — 3,320 −$65,556
Hanlin GaoChief Scientific Officer 0 2 — 2,612 −$51,576

Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.

Insider-activity score

0/ 100

Net insider sales
0 distinct buyers0 buy · 4 sell tx

Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →

Get alerted when insiders buy the stocks you own

Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.

Free for everyone right now · no card · nothing to buy

Start free

How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).

Insider Buying at FLGT

No open-market insider purchases (Form 4 code P) were reported for FLGT between May 18, 2026 and Oct 28, 2026. The filings below may include other transaction types — sales, grants, option exercises, and tax withholding — shown for completeness; they are not open-market purchases.

Recent Form 4 filings

Source: SEC EDGAR Form 4 · transaction codes explained

Hanlin Gao Chief Scientific Officer · filed Oct 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 1,645 $20.22 984,472 −0.2% Oct 26, 2026

† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.

Jian Xie President and COO · filed Oct 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 4,361 $20.22 355,563 −1.2% Oct 26, 2026
Paul Kim CFO and Treasurer · filed Oct 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 2,748 $20.22 353,795 −0.8% Oct 26, 2026
Jian Xie President and COO · filed Sep 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 2,127 $19.66 359,924 −0.6% Sep 2, 2026

“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.

Hanlin Gao Chief Scientific Officer · filed Sep 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 1,673 $19.66 986,117 −0.2% Sep 2, 2026
Ming Hsieh Chief Executive Officer · filed Sep 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 4,392 $19.59 885,952 −0.5% Sep 1, 2026
Paul Kim CFO and Treasurer · filed Sep 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 2,087 $19.59 356,543 −0.6% Sep 1, 2026
Jian Xie President and COO · filed Aug 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 1,193 $19.91 362,051 −0.3% Aug 27, 2026
Hanlin Gao Chief Scientific Officer · filed Aug 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 939 $19.91 987,790 −0.1% Aug 27, 2026
Ming Hsieh Chief Executive Officer · filed Aug 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 2,949 $19.81 890,344 −0.3% Aug 26, 2026
Paul Kim CFO and Treasurer · filed Aug 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 1,168 $19.81 358,630 −0.3% Aug 26, 2026
Paul Kim CFO and Treasurer · filed Jul 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 2,747 $19.67 359,798 −0.8% Jul 26, 2026
Jian Xie President and COO · filed Jul 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 4,361 $19.67 363,244 −1.2% Jul 26, 2026
Hanlin Gao Chief Scientific Officer · filed Jul 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 1,645 $19.67 988,729 −0.2% Jul 26, 2026
Jian Xie President and COO · filed Jun 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 2,146 $17.89 367,605 −0.6% Jun 2, 2026
Hanlin Gao Chief Scientific Officer · filed Jun 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 1,688 $17.89 990,374 −0.2% Jun 2, 2026
Ming Hsieh Chief Executive Officer · filed Jun 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 4,392 $18.09 893,293 −0.5% Jun 1, 2026
Paul Kim CFO and Treasurer · filed Jun 3, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 2,087 $18.09 362,545 −0.6% Jun 1, 2026
Jian Xie President and COO · filed May 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 1,201 $17.60 369,751 −0.3% May 27, 2026
Hanlin Gao Chief Scientific Officer · filed May 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Open-market sale 10b5-1 box not checked 945 $17.60 992,062 −0.1% May 27, 2026
Paul Kim CFO and Treasurer · filed May 28, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 1,168 $17.67 364,632 −0.3% May 26, 2026
Ming Hsieh Chief Executive Officer · filed May 27, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Tax withholding 2,949 $17.67 897,685 −0.3% May 26, 2026
Michael Nohaile Director · filed May 18, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award Stock Option (Right to Buy) 8,426 — — — May 14, 2026
Grant / award 5,558 — 24,578 +29% May 14, 2026
Linda Dong Director · filed May 18, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 11,117 — 38,758 +40% May 14, 2026
Regina E. Groves Director · filed May 18, 2026 · SEC ↗
TransactionSharesPriceHeld afterChange†Date
Grant / award 11,117 — 28,099 +65% May 14, 2026

Insider filings reported around the same time

Other companies whose most recent Form 4 was filed closest to FLGT's (Oct 28, 2026).

Frequently asked about FLGT insider activity

How many insiders bought FLGT stock in these Form 4 filings?

No open-market purchases (Form 4 code P) of FLGT shares were reported by Fulgent Genetics, Inc. insiders between May 18, 2026 and Oct 28, 2026. The 25 filings shown on this page cover other transaction types — sales, grants, option exercises, and tax withholding.

Who filed the most recent Form 4 for FLGT?

The most recent Form 4 on this page was filed by Paul Kim (CFO and Treasurer) on Oct 28, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.

What was the largest open-market FLGT insider sale shown?

The largest open-market sale among the filings shown was 2,127 FLGT shares at $19.66 (about $41,809) by Jian Xie (President and COO) on Sep 2, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.

New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.

Get insider alerts for FLGT — and your whole portfolio

Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy

This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.

Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.